Scientists uncover "genomic tug of war" that influences chemotherapy's effectiveness

[News]

Some patients with myelodysplastic syndromes, like acute myeloid leukemia, benefit from a chemotherapy drug called decitabine that stunts cancer growth. But many others are resistant to decatibine's effects or become resistant over time.

More... (https://www.news-medical.net/news/20231116/Scientists-uncover-genomic-tug-of-war-that-influences-chemotherapys-effectiveness.aspx)